The contribution of deregulated chromatin architecture, including topologically associated domains (TADS), to cancer progression remains ambiguous. CTCF is a central regulator of higher-order chromatin structure that undergoes copy number loss in over half of all breast cancers, but the impact of this defect on epigenetic programming and chromatin architecture remains unclear. We find that under physiological conditions, CTCF organizes sub-TADs to limit the expression of oncogenic pathways, including PI3K and cell adhesion networks. Loss of a single CTCF allele potentiates cell invasion through compromised chromatin insulation and a reorganization of chromatin architecture and histone programming that facilitates de novo promoter-enhancer contacts. However, this change in the higher-order chromatin landscape leads to a vulnerability to inhibitors of mTOR. These data support a model whereby sub-TAD reorganization drives both the modification of histones at de novo enhancer promoter-contacts and transcriptional upregulation of oncogenic transcriptional networks.